241 related articles for article (PubMed ID: 24040311)
61. Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.
Jin Y; He Z; Liang D; Zhang Q; Zhang H; Deng Q; Robertson ES; Lan K
J Virol; 2012 May; 86(9):4956-69. PubMed ID: 22379075
[TBL] [Abstract][Full Text] [Related]
62. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
63. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
Ohsaki E; Suzuki T; Karayama M; Ueda K
Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
[TBL] [Abstract][Full Text] [Related]
64. Regulation of KSHV Latency and Lytic Reactivation.
Broussard G; Damania B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
[TBL] [Abstract][Full Text] [Related]
65. Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections.
Kirsch P; Stein SC; Berwanger A; Rinkes J; Jakob V; Schulz TF; Empting M
Eur J Med Chem; 2020 Sep; 202():112525. PubMed ID: 32634628
[TBL] [Abstract][Full Text] [Related]
66. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.
Juillard F; de Miranda MP; Li S; Franco A; Seixas AF; Liu B; Álvarez ÁL; Tan M; Szymula A; Kaye KM; Simas JP
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22443-22451. PubMed ID: 32820070
[TBL] [Abstract][Full Text] [Related]
67. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
68. Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region.
Su L; Liao Q; Wu Y; Chen X
PLoS One; 2011 Apr; 6(4):e19106. PubMed ID: 21544244
[TBL] [Abstract][Full Text] [Related]
69. Identification of Viral and Host Proteins That Interact with Murine Gammaherpesvirus 68 Latency-Associated Nuclear Antigen during Lytic Replication: a Role for Hsc70 in Viral Replication.
Salinas E; Byrum SD; Moreland LE; Mackintosh SG; Tackett AJ; Forrest JC
J Virol; 2016 Feb; 90(3):1397-413. PubMed ID: 26581985
[TBL] [Abstract][Full Text] [Related]
70. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.
Weidner-Glunde M; Mariggiò G; Schulz TF
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446671
[TBL] [Abstract][Full Text] [Related]
71. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.
Chen W; Hilton IB; Staudt MR; Burd CE; Dittmer DP
J Virol; 2010 Apr; 84(8):3898-908. PubMed ID: 20130056
[TBL] [Abstract][Full Text] [Related]
72. LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes.
Dabral P; Babu J; Zareie A; Verma SC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723020
[TBL] [Abstract][Full Text] [Related]
73. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
Sarek G; Järviluoma A; Moore HM; Tojkander S; Vartia S; Biberfeld P; Laiho M; Ojala PM
PLoS Pathog; 2010 Mar; 6(3):e1000818. PubMed ID: 20333249
[TBL] [Abstract][Full Text] [Related]
74. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Fukumoto H; Kanno T; Hasegawa H; Katano H
Front Microbiol; 2011; 2():175. PubMed ID: 21904536
[TBL] [Abstract][Full Text] [Related]
75. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.
Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R
J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111
[TBL] [Abstract][Full Text] [Related]
76. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
77. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
78. KSHV Genome Replication and Maintenance.
Purushothaman P; Dabral P; Gupta N; Sarkar R; Verma SC
Front Microbiol; 2016; 7():54. PubMed ID: 26870016
[TBL] [Abstract][Full Text] [Related]
79. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
80. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
